Ketogenic Feeding for Muscle Preservation After Trauma

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of this study is to determine whether a ketogenic diet, provided as tube feeding, compared with a standard hospital tube feeding, is safe and feasible and helps preserve muscle mass and improve metabolic health in adults aged 55 years and older hospitalized with traumatic injury.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 55 years and older

Traumatic injury

Expected to survive and at least 10-day stay in the hospital

Expected to be enterally fed for at least 10 days

Disqualifiers

Failure to provide informed consent

Moribund

Vegeterian/vegan

Diagnosed dementia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ketogenic feeding

    Behavioral

    The ketogenic feeding will have a macronutrient composition of approximately 10% energy from carbohydrates, 25% energy from protein, and 65% energy from fat.

  • Standard feeding

    Behavioral

    The participants will receive standard hospital care feeding.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Ketogenic feedingExperimental treatment 1 intervention
Group B: Standard feedingPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of Adverse Events

Number of adverse events collected using a standardized adverse event reporting form (Unit: Count of events).

Time frame
At baseline and 10-day of feeding
2

Adherence to the Intervention

Percentage of prescribed intervention sessions completed, assessed through adherence logs and system usage records (Unit: %)

Time frame
From baseline to 10 days follow-up.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: